-
-
-
-
-
-
-
Beam, Inc. (BEAM) Misses Q1 EPS by 3c
-
-
-
-
-
-
-
Beam Therapeutics to Hold Conference Call to Discuss Third Quarter 2024 Financial Results and Abstracts Accepted for Presentation at ASH Annual Meeting
-
-
-
-
-
-
-
Beam, Inc. (BEAM) Tops Q3 EPS by 11c
-
-
-
-
-
-
-
Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
-
-
-
-
-
-
-
Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
Pfizer (PFE) Enters Exclusive Collaboration with Beam (BEAM) for Novel In Vivo Base Editing Programs for a Range of Rare Diseases
-
-
-
-
-
-
-
Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results
-
1,198,712 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

